These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 26062540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
    Lana S, U'ren L, Plaza S, Elmslie R, Gustafson D, Morley P, Dow S.
    J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
    U'Ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW.
    J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
    [Abstract] [Full Text] [Related]

  • 4. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
    Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO.
    Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
    [Abstract] [Full Text] [Related]

  • 5. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
    Batschinski K, Nobre A, Vargas-Mendez E, Tedardi MV, Cirillo J, Cestari G, Ubukata R, Dagli MLZ.
    Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
    Sorenmo K, Samluk M, Clifford C, Baez J, Barrett JS, Poppenga R, Overley B, Skorupski K, Oberthaler K, Van Winkle T, Seiler G, Shofer F.
    J Vet Intern Med; 2007 Sep; 21(6):1347-54. PubMed ID: 18196746
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
    Matsuyama A, Poirier VJ, Mantovani F, Foster RA, Mutsaers AJ.
    J Am Anim Hosp Assoc; 2017 Sep; 53(6):304-312. PubMed ID: 28892429
    [Abstract] [Full Text] [Related]

  • 9. Surgery and doxorubicin in dogs with hemangiosarcoma.
    Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ.
    J Vet Intern Med; 1996 Sep; 10(6):379-84. PubMed ID: 8947871
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ, Philibert JC, Siegel S, Clifford CA, Risbon R, Zivin K, Cronin KL.
    J Am Vet Med Assoc; 2008 Jul 01; 233(1):122-8. PubMed ID: 18593321
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
    Gedney A, Salah P, Mahoney JA, Krick E, Martins R, Scavello H, Lenz JA, Atherton MJ.
    Vet Comp Oncol; 2022 Sep 01; 20(3):688-696. PubMed ID: 35442554
    [Abstract] [Full Text] [Related]

  • 15. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
    London CA, Gardner HL, Mathie T, Stingle N, Portela R, Pennell ML, Clifford CA, Rosenberg MP, Vail DM, Williams LE, Cronin KL, Wilson-Robles H, Borgatti A, Henry CJ, Bailey DB, Locke J, Northrup NC, Crawford-Jakubiak M, Gill VL, Klein MK, Ruslander DM, Thamm DH, Phillips B, Post G.
    PLoS One; 2015 Sep 01; 10(4):e0124889. PubMed ID: 25923466
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.
    Teske E, Rutteman GR, Kirpenstein J, Hirschberger J.
    Vet Comp Oncol; 2011 Dec 01; 9(4):283-9. PubMed ID: 22077409
    [Abstract] [Full Text] [Related]

  • 17. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
    Faroni E, Sabattini S, Guerra D, Iannuzzi C, Chalfon C, Agnoli C, Stefanello D, Polton G, Ramos S, Aralla M, Ciaccini R, Foglia A, Okonji S, Marconato L.
    Vet Comp Oncol; 2023 Mar 01; 21(1):123-130. PubMed ID: 36633399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
    Borgatti A, Fieberg A, Winter AL, Stuebner K, Taras E, Todhunter D, Masyr A, Rendhal A, Vallera DA, Koopmeiners JS, Modiano JF.
    Vet Comp Oncol; 2020 Dec 01; 18(4):664-674. PubMed ID: 32187827
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.